BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting - - IND clearance expands Company's advanced clinical pipeline for ...

BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease ...

BioRestorative Therapies (BRTX) announced the U.S. Food and Drug Administration has cleared its Investigational New Drug application for ...

Many patients with lower back pain, sciatica, pain down the back of the legs, or weakness of the lower-extremity muscles are diagnosed with a herniated (a.k.a. compressed or ruptured) spinal disc.

BROOMFIELD, Colo., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that ...

Background: The meta-analysis aimed to estimate the efficacy of mesenchymal stem cells on lumbar discogenic pain in patients with intervertebral disc degeneration. Methods: A comprehensive literature ...

2002; van Tulder and Koes, 2006). The etiology of LBP is characterized by diversity and complexity. At least 40% of LBP cases may be related to intervertebral disk (IVD) degeneration, that is, ...

Medically reviewed by Katrina Carter, DPT Neck pain from sleeping is often related to your sleeping position—particularly if ...